Delivery Order SPE2DB24D2010-SPE2DB25FZSC5

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,145.15 firm fixed-price delivery order is for the supply of 4,568,231,618 tablets of the medication Briviact 50 mg. The contract has an ultimate completion date of May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 25 mg tablets. The contract, valued at $2,484.06, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $5,107.02, is a firm fixed price delivery order for the supply of the pharmaceutical product Briviact 50 mg tablets. The contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Briviact in 100 mg tablet form. The $2,871.03 firm fixed-price delivery order has an ultimate completion date of October 12, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 50 mg tablets. The contract has a ceiling value of $4,281.65 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price delivery order contract, which means Amerisourcebergen will provide the specified pharmaceutical product at a pre-determined price. Amerisourcebergen holds a larger...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,410.56 Delivery Order contract is for the supply of Briviact 100 mg tablets, a prescription medication. The contract has a firm fixed price and an ultimate completion date of June 18, 2024. Amerisourcebergen, as a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.19 firm fixed price delivery order is for the supply of 60 tablets of the prescription medication BRIVIACT 100 MG. The contract has an ultimate completion date of June 11, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.50 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of Briviact 100 mg tablet 60s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,528.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 11, 2024, with a completion date of December 12, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 100 mg tablets. The contract has a ceiling value of $1,655.44 and an ultimate completion date of September 11, 2023. It is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZSC5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,215.40 firm fixed-price delivery order is for the pharmaceutical product Briviact 100 mg tablet 60s. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which cover a comprehensive range of pharmaceutical and medical supply procurement for federal healthcare programs. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 1/22/25, 9:15 AM